Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Klaus

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
NMR in Biomedicine|October 30, 2015
Simultaneous calcium fluorescence imaging and MR of ex vivo organotypic cortical cultures: a new test bed for functional MRIRuiliang Bai, Andreas Klaus, Tim Bellay, et al.
BMC Medicine|September 11, 2012
Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?Sabrina Ehnert, Jian Zhao, Stefan Pscherer, et al.
Scientific Reports|October 25, 2017
Toxoplasma-induced changes in host risk behaviour are independent of parasite-derived AaaH2 tyrosine hydroxylaseCristina Afonso, Vitor B Paixão, Andreas Klaus, et al.
Nature|December 13, 2023
Dynamic behaviour restructuring mediates dopamine-dependent credit assignmentJonathan C Y Tang, Vitor Paixao, Filipe Carvalho, et al.
Journal of Agricultural and Food Chemistry|May 17, 2023
Biocatalytic Production of Odor-Active Fatty Aldehydes from Fungal LipidsJean-Philippe Kanter, Philipp Jakob Honold, David Luh, et al.
Diagnostics (Basel, Switzerland)|January 30, 2016
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine TumorYin Wu, Andreas Klaus Pfeifer, Rebecca Myschetzky, et al.
Neuroendocrinology|February 22, 2011
Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in SwitzerlandAndreas Klaus Pfeifer, Tine Gregersen, Henning Grønbæk, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 22, 2016
Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?Sabrina Ehnert, Romina Haydée Aspera-Werz, Thomas Freude, et al.
Applied Microbiology and Biotechnology|August 30, 2022
An enzymatic tandem reaction to produce odor-active fatty aldehydesJean-Philippe Kanter, Philipp Jakob Honold, David Lüke, et al.
Foods (Basel, Switzerland)|September 28, 2024
Exploring the Impact of Solid-State Fermentation on Fava Bean Flour: A Comparative Study of <i>Aspergillus oryzae</i> and <i>Rhizopus oligosporus</i>Ophélie Gautheron, Laura Nyhan, Maria Garcia Torreiro, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
NMR in Biomedicine|October 30, 2015
Simultaneous calcium fluorescence imaging and MR of ex vivo organotypic cortical cultures: a new test bed for functional MRIRuiliang Bai, Andreas Klaus, Tim Bellay, et al.
BMC Medicine|September 11, 2012
Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?Sabrina Ehnert, Jian Zhao, Stefan Pscherer, et al.
Scientific Reports|October 25, 2017
Toxoplasma-induced changes in host risk behaviour are independent of parasite-derived AaaH2 tyrosine hydroxylaseCristina Afonso, Vitor B Paixão, Andreas Klaus, et al.
Nature|December 13, 2023
Dynamic behaviour restructuring mediates dopamine-dependent credit assignmentJonathan C Y Tang, Vitor Paixao, Filipe Carvalho, et al.
Journal of Agricultural and Food Chemistry|May 17, 2023
Biocatalytic Production of Odor-Active Fatty Aldehydes from Fungal LipidsJean-Philippe Kanter, Philipp Jakob Honold, David Luh, et al.
Diagnostics (Basel, Switzerland)|January 30, 2016
Induction of Anti-Tumor Immune Responses by Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in a Murine Model of a Human Neuroendocrine TumorYin Wu, Andreas Klaus Pfeifer, Rebecca Myschetzky, et al.
Neuroendocrinology|February 22, 2011
Peptide receptor radionuclide therapy with Y-DOTATOC and (177)Lu-DOTATOC in advanced neuroendocrine tumors: results from a Danish cohort treated in SwitzerlandAndreas Klaus Pfeifer, Tine Gregersen, Henning Grønbæk, et al.
European Surgical Research. Europaische Chirurgische Forschung. Recherches Chirurgicales Europeennes|July 22, 2016
Distinct Gene Expression Patterns Defining Human Osteoblasts' Response to BMP2 Treatment: Is the Therapeutic Success All a Matter of Timing?Sabrina Ehnert, Romina Haydée Aspera-Werz, Thomas Freude, et al.
Applied Microbiology and Biotechnology|August 30, 2022
An enzymatic tandem reaction to produce odor-active fatty aldehydesJean-Philippe Kanter, Philipp Jakob Honold, David Lüke, et al.
Foods (Basel, Switzerland)|September 28, 2024
Exploring the Impact of Solid-State Fermentation on Fava Bean Flour: A Comparative Study of <i>Aspergillus oryzae</i> and <i>Rhizopus oligosporus</i>Ophélie Gautheron, Laura Nyhan, Maria Garcia Torreiro, et al.
Pageof 4